Table 5

Baseline characteristics of proteome analysed RA patients

DemographicsRespondersNon-responders
Age, years5456
Female, %83100
Disease characteristics
RA duration, years199
DAS28 score4.86.5
ESR, mm/h1119
CRP, mg/l816
IgM RF positive, %10050
ACPA positive, %6783
Erosive disease, %6767
Medication
Previous biologicals, n12
> 1 Biological in history, %17100
Previous DMARDS, n4.03.5
Current prednisolone use, %8383
Prednisolone dosage, mg/day108.75
Current MTX use, %8383
MTX dosage, mg/week17.510
Current SSZ use, %1733
Current HCQ use, %3317
  • ACPA, anticyclic citrullinated protein; CRP, C reactive protein; DAS28, 28 joint disease activity score; DMARD, disease modifying antirheumatic drug; ESR, erythrocyte sedimentation rate; HCQ, hydroxychloroquine; IgM, immunoglobulin M; MTX, methotrexate; RA, rheumatoid arthritis; RF, rheumatoid factor; SSZ, sulphasalazyne.